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A review of the literature found that the cryotherapy method used to treat external genital warts (EGWs)
has been applied with varying intervals between sessions. However, no study has compared the intervals
between sessions. The ﬁles of 312 patients who were diagnosed with genital warts and underwent
cryotherapy were retrospectively reviewed. The patients were divided into two groups: 7e8 days be-
tween cryotherapy treatments and 14e21 days between cryotherapy treatments. The number of sessions
and recurrence status were recorded for each patient. Cryotherapy methods applied with short intervals,
such as 7e8 days, are more effective, requiring fewer sessions and less time when compared with longer
intervals (p < 0.0001).
Copyright  2013, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
External genital warts (EGWs) are typically sexually transmitted
benign epidermal growths caused by the human papilloma virus
(HPV).1 Various methods have been used for treatment, including
imiquimod, trichloroacetic acid, podophyllotoxin, cryotherapy,
electrosurgery, topical or systemic interferons, laser surgery,
podophyllin, and surgical excision. Various therapeutic protocols
have been reported in EGW treatment.2,3 However, no speciﬁc
treatment that is appropriate for all patients has been identiﬁed.
Cryotherapy is used to treat EGWs, but different session in-
tervals have been reported in the literature.4e7 However, we found
no comparative study that examined the session intervals.
We report on our experiencewith cryosurgery for the treatment
of EGWs using different session intervals.
Methods
We retrospectively reviewed the ﬁles of 408 patients admitted to
our polyclinic between January 2008 and January 2012. We recor-
ded parameters including sex, age, previous treatment records,
cryotherapy session intervals, number of sessions, adverse effects
observed after cryotherapy, and recurrence after treatment. In
September 2012, we phoned the 312 patients who underwent onlyy have no ﬁnancial or non-
tter or materials discussed in
lvarı Basmane, Izmir, Turkey.
iwanese Dermatological Associatiocryotherapy sessions and inquired about their current well-being
and recurrence. We administered cryotherapy to treat EGWs in
sessions with intervals of 2e3 weeks until August 2010. We then
began to administer cryotherapy in sessions with intervals of 7e8
days. We divided the patients into two groups according to the
session interval and evaluated the differences between groups.
Patients who did not receive any medical treatment for genital
warts for at least 6 months were included in the study, and those
with a history of keloid or cold sensitivity were excluded.
A liquid nitrogen spray (Cry-AC; Brymill Cryogenic Systems,
Basingstoke, UK) was used to perform cryosurgery. The open spray
technique was used for all patients. The patients received two
freezeethaw cycles in each session.We used nozzle C (0.06mm) for
all of the lesions, and continuous spraying was used for freezing
according towart size. The entirety of each lesionwas frozenwith a
1-mm margin (Figure 1). While freezing the tissue, a distance of
0.5e1 cm was maintained between the nozzle and the skin.
After the completion of treatment, the patients were asked to
monitor themselves and to present to our clinic if they experienced
any adverse effects. The patients who did not report recurrence
were considered to be in remission.
Continuous variables are reported as the mean and standard
deviation. Categorical data are reported as the number and percent.
The Kolmogorov-Smirnov test was used to conﬁrm a normal data
distribution. The Student t test was used to compare continuous
variables between groups. A p value <0.05 was considered signif-
icant. Statistical analyses were performed using SPSS software
(Statistical Package for the Social Sciences version 20.0; SSPS Inc.,
Chicago, IL, USA).n. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 A view of the patient’s genitalia immediately after the second session of
cryotherapy application (8 days after the ﬁrst session).
Figure 2 Distribution of the number of sessions administered to the groups.
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Results
In total, 254 males and 58 females were included in the study. The
youngest patient was 18 years old, and the oldest was 61 years old;
the mean age was 33.46  8.811 years. Cryotherapy was adminis-
tered to 207 patients (Group 1) with a 7e8-day interval and to 105
patients (Group 2) with a 14e21-day interval. Before admission to
our clinic, 14 patients underwent electrocautery, 16 received cryo-
therapy, eight received both cryotherapy and electrocautery, seven
received topical imiquimod cream, and 267 received no therapy.
The patients underwent a minimum of two and a maximum of 25
sessions, with a mean of 6.90  3.161 sessions. Group 1 underwent
a mean of 6.04  2.319 sessions, and Group 2 underwent a mean of
8.60  3.852 sessions (Figure 2). Eight (4.34%) recurrences were
observed in Group 1, but 23 patients in this group were lost to
follow-up. Eleven (14.66%) recurrences were observed in Group 2,
but 30 patients were lost to follow-up. We observed only three
patients with recurrence after 6 monthsdone of them was in
Group 1 (0.54%), two of themwere in Group 2 (2.66 %). Nearly every
patient experienced blistering or hemorrhagic blistering, but none
of the patients developed a permanent scar as a complication. Only
ﬁve patients reported pigmentation changes at the site of cry-
otherapydtwo of themwere in Group 1 (1.08%), three of themwere




typically sexually transmitted; however, rare vertical transmissionand autoinoculation are also observed. Among all sexually trans-
mitted diseases, anogenital HPV infections are the most prevalent
worldwide. Each year, 30 million new cases are reported. There are
various subclinical infections. Anogenital warts have a prevalence of
1e2% among sexually active individuals between the ages of 15 years
and 49 years. Of the more than 100 HPV genotypes identiﬁed, nearly
half cause infections in the genital tract.8
HPV types 6 and 11, which are believed to have a low risk, are
the most common causes of genital warts. By contrast, HPV types
31, 33, 45, 51, 52, 56, 58, and 59 are considered to have an inter-
mediate level of risk. These types cause squamous intraepithelial
neoplasia and are considered less common causes of squamous cell
carcinoma. Cervical dysplasia and anogenital cancers are strongly
associated with HPV types 16 and 18. Patients who have visible
genital warts can be infected simultaneously with multiple HPV
types.9
Treatment protocols for genital warts use both surgical and
nonsurgical methods. Nonsurgical treatment includes the applica-
tion of local agents such as imiquimod, podophyllotoxin, and 5-
ﬂuorouracil. Other local agents used in outpatient treatment set-
tings include trichloroacetic acid (TCA), podophyllin, and the
intralesional application of agents such as interferon and bleomy-
cin. Surgical methods include cryotherapy, electrosurgery, excision,
and laser therapy, which primarily aim to remove visible lesions.
Wart clearance isgenerallyacceptedas thecompleteeradicationof
warts from the treated area, rather than the elimination of HPV.
Although removal of HPV is not the primary goal of treatment, most
patients who experiencewart clearance will become HPV negative.10
Previous studies have reported a 79e88% rate of genital wart
removal by cryotherapy alone or combined with other treatments.
However, despite multiple therapies, 25e39% of cases report
recurrences.11,12
The rate of long-term regression remains unknown. Recurrence
occurs in 25e67% of patients within 3 months after therapy in the
areas previously treated for genital warts, and it is associated with
the reactivation of long-lived cells at the treatment site. Risk factors
for persistence include high-risk types of HPV and old age.12
The literature contains few studies that compare the various
treatment methods and cryotherapy in the treatment of EGWs. In
these studies, cryotherapy was used at different intervals.4e7
However, we were unable to ﬁnd a comparative study on the ses-
sion intervals. Youn et al administered cryotherapy to 560 patients
with hand and foot viral warts at 2- and 3-week intervals.13 They
concluded that a 2-week interval was optimal for cryotherapy, not
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lower recurrence rate, the similar complication rate, and the longer
mean time to recurrence than cryotherapy administered with a 3-
week interval.
In the present study, a 7e8-day interval between cryotherapy
sessionswas found to be effective for EGWs in fewer sessions than a
14e21-day interval (p < 0.0001). The lower recurrence rate
observed with the 7e8-day interval may have resulted from the
early completion of treatment and longer follow-up period in Group
2. Additionally, when compared with other studies, the number of
sessions in our studywas higher, and the recurrence ratewas lower.
However, following the clinical clearance ofwarts, the patientswere
followed for 6 months, and any treatment administered for re-
currenceswithin this periodwas considered as a session.4,11,12 In our
study, the number of males was higher than the number of females,
but female patients typically prefer gynecology polyclinics. Patients
in both of our treatment groups tolerated the procedure well.
Although our study could not evaluate EGW intensity because this
was a retrospective study, no deliberate preference was considered
when placing patients in groups in terms of wart intensity because
we divided the groups by treatment date. For future studies
comparing cryotherapy with another EGW treatment, we suggest
using short cryotherapy session intervals, for example, 7e8 days.
Conclusion
Our results support that shorter intervals between cryotherapy
sessions, such as 7e8 days, can be effective in EGW treatment and
require fewer sessions administered over a shorter time period.
Thus applying cryotherapy with short intervals could increase the
use of this cheap and widely used method.References
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